Market revenue in 2022 | USD 432.4 million |
Market revenue in 2030 | USD 900.7 million |
Growth rate | 9.6% (CAGR from 2022 to 2030) |
Largest segment | Continuous blood glucose monitoring system |
Fastest growing segment | Smart insulin pens |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Smart glucose meter, Continuous blood glucose monitoring system, Smart insulin pens, Smart insulin pumps, Apps |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Roche Holding AG ADR, Bayer AG, Sanofi SA, DexCom Inc, Insulet Corp, PHC Holdings Corp, B. Braun Medical, Brigade High Income Founders |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital diabetes management market will help companies and investors design strategic landscapes.
Continuous blood glucose monitoring system was the largest segment with a revenue share of 40.7% in 2022. Horizon Databook has segmented the Japan digital diabetes management market based on smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, apps covering the revenue growth of each sub-segment from 2018 to 2030.
Key drivers of the market are the increasing elderly population, growing incidence of diabetes, and the launch of innovative products in digital diabetes. Diabetes has become a major health concern in all OECD countries. In 2016, the age standard prevalence of diabetes was 12.1% (16.3% for men and 9.3% for women) according to the Ministry of Health, Labour, and Welfare (MHLW).
Furthermore, growth in government initiatives and favorable reimbursement policies are expected to drive the market during the forecast period. For instance, in August 2017, Japan’s MHLW granted reimbursements for FreeStyle Libre glucose monitoring system.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan digital diabetes management market, including forecasts for subscribers. This country databook contains high-level insights into Japan digital diabetes management market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account